DELAWARE
|
001-34079
|
11-3516358
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
15245 Shady Grove Road, Suite 455
|
|
20850
|
Rockville, MD
|
|
(Zip Code)
|
(Address of Principal Executive Offices)
|
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
|
(d)
|
Exhibits.
|
Exhibit
Number
|
|
Description
|
|
99.1 |
Press release dated January 17, 2012.
|
|
Rexahn Pharmaceuticals, Inc.
|
||
|
|
||
Date: January 17, 2012
|
By:
|
/s/ Tae Heum Jeong
|
|
|
|
Name:
|
Tae Heum Jeong
|
|
|
Title:
|
Chief Financial Officer
|